Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-18

Clinical Trial Update: Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate

View source ↗

Summary

Clinical trial evaluating how bone turnover markers predict outcomes during discontinuation of alendronate in osteoporosis; completed with results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • alendronate (alendronate)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Osteoporosis | Status: COMPLETED | Results posted: 2021-03-18